H
Huimei An
Researcher at Peking University
Publications - 21
Citations - 244
Huimei An is an academic researcher from Peking University. The author has contributed to research in topics: Positive and Negative Syndrome Scale & Medicine. The author has an hindex of 6, co-authored 16 publications receiving 132 citations.
Papers
More filters
Journal ArticleDOI
Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients
Huimei An,Xiangdong Du,Xingbing Huang,Lingyan Qi,Qiufang Jia,Guangzhong Yin,Chunling Xiao,Xu-Feng Huang,Yuping Ning,Ryan M. Cassidy,Li Wang,Jair C. Soares,Xiang Yang Zhang,Xiang Yang Zhang +13 more
TL;DR: The results suggested that oxidative stress may play an important role in antipsychotic-induced weight gain and further investigations using the longitudinal design in first-episode schizophrenia patients are needed to explore the beneficial effect of antioxidants on the abnormal lipid metabolism mediated by antipsychotics.
Journal ArticleDOI
Glucose disturbances in first-episode drug-naïve schizophrenia: relationship to psychopathology
Xiang Yang Zhang,Xiang Yang Zhang,Da Chun Chen,Yun Long Tan,Huimei An,Giovana Zunta-Soares,Xu-Feng Huang,Jair C. Soares +7 more
TL;DR: Examination of glucose and lipid metabolism in first-episode and drug naïve patients with schizophrenia and their relationships with psychopathology suggest abnormal glucose metabolism may be associated with the pathogenesis and psychopathology of schizophrenia in the early phases of the disease process.
Journal ArticleDOI
Gut Microbiome Composition Associated With Major Depressive Disorder and Sleep Quality
TL;DR: In this paper, the authors performed 16S rRNA sequencing of stool samples from 36 patients with major depressive disorder and 45 healthy controls (HC) and found that six microbiota targets were associated with the severity of depression, 11 with sleep quality, and 3 with sleep severity.
Journal ArticleDOI
Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.
Jinghui Tong,Junchao Huang,Xingguang Luo,Song Chen,Yimin Cui,Huimei An,Meihong Xiu,Shuping Tan,Zhiren Wang,Ying Yuan,Jianxin Zhang,Fude Yang,Chiang-Shan R. Li,L. Elliot Hong,Yunlong Tan +14 more
TL;DR: Elevated levels of NMDar antibody may play a role in the pathogenesis of schizophrenia, leading to NMDAR dysfunction, thereby inducing symptoms of psychosis and cognitive impairment, and may serve as a biomarker and provide a new avenue for treatment of schizophrenia.
Journal ArticleDOI
Plasma total antioxidant status and cognitive impairments in first-episode drug-naïve patients with schizophrenia.
Ting Xie,Qiongwei Li,Xingguang Luo,Li Tian,Zhiren Wang,Shuping Tan,Song Chen,Guigang Yang,Huimei An,Fude Yang,Yunlong Tan +10 more
TL;DR: The results suggested that oxidative stress may be involved in the pathophysiology of schizophrenia at the early of stage and its cognitive impairment.